{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T23:44:38Z","timestamp":1785714278976,"version":"3.56.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":109,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mammary Gland Biol Neoplasia"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10911-026-09602-1","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T13:06:43Z","timestamp":1776344803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A-to-I RNA Editing Endows miR-3664-5p with Carcinogenicity in Breast Cancer Through Modulating LONP2 Mediated Glycolysis"],"prefix":"10.1007","volume":"31","author":[{"given":"Yajing","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueli","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"9602_CR1","doi-asserted-by":"crossref","unstructured":"Sierra P, Harjot A, Anne Claudine B, Armen P. Role of AURKB Inhibition in Reducing Proliferation and Enhancing Effects of Radiotherapy in Triple-Negative Breast Cancer. Breast Cancer (Dove Med Press). 2024;16:341\u20136.","DOI":"10.2147\/BCTT.S444965"},{"key":"9602_CR2","doi-asserted-by":"crossref","unstructured":"Leyang W, Liyuan Q, Shuhui Z, Jiahui Q, Zengzheng D, Ying S, Xiaoyao C, Lin L, Chenyang L, Xinyue Q, Xingpeng Y, Zichun H. Dual-Engineered Macrophage-Microbe Encapsulation for Metastasis Immunotherapy. Adv Mater. 2024;36:e2406140.","DOI":"10.1002\/adma.202406140"},{"key":"9602_CR3","doi-asserted-by":"crossref","unstructured":"Kai-Ming Z, De-Chang Z, Ze-Yu L, Yan W, Jian-Nan L, Tian D, Ling Z, Yu-Hong C, Qi-Chao Y, Qing-Shan C, Rui-Zhao C, Zi-Xuan Z, Jia-Lu S, Bing-Xin H, Hai-Liang Z, Gong-Kan F, Xiao-Feng Z, Jun T, Rong D. Inactivated cGAS-STING Signaling Facilitates Endocrine Resistance by Forming a Positive Feedback Loop with AKT Kinase in ER+HER2- Breast Cancer. Adv Sci (Weinh). 2024;11:e2403592.","DOI":"10.1002\/advs.202403592"},{"key":"9602_CR4","doi-asserted-by":"crossref","unstructured":"Yan L, Jiahui C, Jia T, Yu H, Xinxing M, Yehui Z, Liangzhu F. Engineered CAR-NK cells with tolerance to H2O2 and hypoxia can suppress postoperative relapse of triple-negative breast cancers. Cancer Immunol Res. 2024;12:1574\u201388.","DOI":"10.1158\/2326-6066.CIR-23-1017"},{"key":"9602_CR5","doi-asserted-by":"crossref","unstructured":"Lin J, Junning P, Nan S, Hongying C, Zhenyu L, Wenhui Z, Qingyuan Z, Liru L. Effect of PR status on the prognosis of advanced ER-high HER2-negative breast cancer patients receiving CDK4\/6 inhibitor combined with endocrine as first-line therapy. BMC Cancer. 2024;24:850.","DOI":"10.1186\/s12885-024-12621-y"},{"key":"9602_CR6","doi-asserted-by":"crossref","unstructured":"Lizhao W, Jianpeng L, Nan M, Heyan C, Ligang N, Jianjun H, Ru W. Identifying subtypes and developing prognostic models based on N6-methyladenosine and immune microenvironment related genes in breast cancer. Sci Rep. 2024;14:16586.","DOI":"10.1038\/s41598-024-67477-w"},{"key":"9602_CR7","doi-asserted-by":"crossref","unstructured":"Philipp R, Carolin F, Nicolai W, Charlotte PW, Sabrina K, John FY, Daniel TH, Jenna F, Michelle E, Nils W, Maximilian F, Laura SP, Annika ES, Yvonne F, Erez YL, Gail M, Thorsten S. Precise in vivo RNA base editing with a wobble-enhanced circular CLUSTER guide RNA. Nat Biotechnol. 2024;43:545\u201357.","DOI":"10.1038\/s41587-024-02313-0"},{"key":"9602_CR8","doi-asserted-by":"crossref","unstructured":"Wan-Bing T, Jun X, Bi-Feng Y. Site-specific quantification of Adenosine-to-Inosine RNA editing by Endonuclease-Mediated qPCR. Bioorg Med Chem. 2024;110:117837.","DOI":"10.1016\/j.bmc.2024.117837"},{"key":"9602_CR9","doi-asserted-by":"crossref","unstructured":"Miguel RLS, Brian HK, Ariela BG, Gauri G, Andy Y, Pardis A, Lora EL, Eric V, John FF, Pengfei D, Eric P, Sarah Z, Deepak AK, Ryan CT, Donjing L, You Jeong P, Esther C, Kimia Z, Emily M, Brian F, Lillian W, Hannah S, Lisa ML, Brendan S, Vanessa C, Prashant K, Claudia F, Jessica SJ, Marysia-Kolbe R, Joseph S, Girish NN, Minghui W, Bin Z, Pamela S, Noam DB, Eric ES, Panos R, Alexander WC. Michael S B. Divergent landscapes of A-to-I editing in postmortem and living human brain. Nat Commun. 2024;15:5366.","DOI":"10.1038\/s41467-024-49268-z"},{"key":"9602_CR10","doi-asserted-by":"crossref","unstructured":"Houhong W, Xiaoyu W, Lu L, Junfeng Z, Heng L. Suppression of A-to-I RNA-editing enzyme ADAR1 sensitizes hepatocellular carcinoma cells to oxidative stress through regulating Keap1\/Nrf2 pathway. Exp Hematol Oncol. 2024;13:30.","DOI":"10.1186\/s40164-024-00494-7"},{"key":"9602_CR11","doi-asserted-by":"crossref","unstructured":"Weimin L, Hao W, Jinxia L, Zhuo W, Miao C, Xiaoli L, Ganqiang L. Transcriptomic analysis reveals associations of blood-based A-to-I editing with Parkinson\u2019s disease. J Neurol. 2023;271:976\u201385.","DOI":"10.1007\/s00415-023-12053-x"},{"key":"9602_CR12","doi-asserted-by":"crossref","unstructured":"Gjendine V, James RC, Yvonne C. Functional consequences of A-to-I editing of miR-379 in prostate cancer cells. Sci Rep. 2023;13:16602.","DOI":"10.1038\/s41598-023-43775-7"},{"key":"9602_CR13","doi-asserted-by":"crossref","unstructured":"Marzieh G, Ali A, Reza Y, Rezvan N, Ladan T-T. Through oxaliplatin resistance induction in colorectal cancer cells, increasing ABCB1 level accompanies decreasing level of miR-302c-5p, miR-3664-5p and miR-129-5p. Biomed Pharmacother. 2018;108:1070\u201380.","DOI":"10.1016\/j.biopha.2018.09.112"},{"key":"9602_CR14","unstructured":"Yuwen J, Haojun Y, Jun Q, Yu G, Hanyang L, Siyuan W, Liang C, Liming T. miR\u20133664\u20135P suppresses the proliferation and metastasis of gastric cancer by attenuating the NF\u2013\u03baB signaling pathway through targeting MTDH. Int J Oncol. 2019;54:845\u201358."},{"key":"9602_CR15","doi-asserted-by":"crossref","unstructured":"Xiaobo C, Yali Z, Le Z, Jiayi L, Yunfei B, Yanru C, Boqian W, Shu Z, Xin L. Role of LONP2 in head and neck squamous cell carcinoma. Gene. 2022;851:147033.","DOI":"10.1016\/j.gene.2022.147033"},{"key":"9602_CR16","doi-asserted-by":"crossref","unstructured":"Wanrong W, Fulin L, Kejia W, Yurou C, Hanshu W, Guo D, Wei Z. Lon Peptidase 2, Peroxisomal (LONP2) Contributes to Cervical Carcinogenesis via Oxidative Stress. Med Sci Monit. 2018;24:1310\u201320.","DOI":"10.12659\/MSM.908966"},{"key":"9602_CR17","doi-asserted-by":"crossref","unstructured":"Laura CDP, Rachel R, Kelvin JAD. The peroxisomal Lon protease LonP2 in aging and disease: functions and comparisons with mitochondrial Lon protease LonP1. Biol Rev Camb Philos Soc. 2016;92:739\u201353.","DOI":"10.1111\/brv.12253"},{"key":"9602_CR18","doi-asserted-by":"crossref","unstructured":"Dominic BB, Kowcee J, Martina B, Karl XK, Marc G, Alexandra S, J\u00fcrgen BJJCB. Pgam5 released from damaged mitochondria induces mitochondrial biogenesis via Wnt signaling. 2018;217:1383\u201394.","DOI":"10.1083\/jcb.201708191"},{"key":"9602_CR19","doi-asserted-by":"publisher","first-page":"e18465","DOI":"10.1111\/jcmm.18465","volume":"28","author":"Z Liu","year":"2024","unstructured":"Liu Z, Li W, Wang Z, Yang Q, Chen L, Chen W, Qu X. EIF4A3-Induced CircDHTKD1 regulates glycolysis in non-small cell lung cancer via stabilizing PFKL. J Cell Mol Med. 2024;28:e18465.","journal-title":"J Cell Mol Med"},{"key":"9602_CR20","doi-asserted-by":"publisher","first-page":"16561","DOI":"10.1038\/s41598-024-67379-x","volume":"14","author":"Y Chu","year":"2024","unstructured":"Chu Y, Ge D, Zhou J, Liu Y, Zheng X, Liu W, Ke L, Lu Y, Chu Y. Controlling glycolysis to generate characteristic volatile organic compounds of lung cancer cells. Sci Rep. 2024;14:16561.","journal-title":"Sci Rep"},{"key":"9602_CR21","doi-asserted-by":"publisher","first-page":"e1012238","DOI":"10.1371\/journal.ppat.1012238","volume":"20","author":"Z Wang","year":"2024","unstructured":"Wang Z, Bian Z, Wang D, Xu J. Functions and mechanisms of A-to-I RNA editing in filamentous ascomycetes. PLoS Pathog. 2024;20:e1012238.","journal-title":"PLoS Pathog"},{"key":"9602_CR22","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.1038\/s41467-024-48336-8","volume":"15","author":"C Feng","year":"2024","unstructured":"Feng C, Xin K, Du Y, Zou J, Xing X, Xiu Q, Zhang Y, Zhang R, Huang W, Wang Q, Jiang C, Wang X, Kang Z, Xu J, Liu H. Unveiling the A-to-I mRNA editing machinery and its regulation and evolution in fungi. Nat Commun. 2024;15:3934.","journal-title":"Nat Commun"},{"key":"9602_CR23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12915-024-01908-y","volume":"22","author":"L Yang","year":"2024","unstructured":"Yang L, Yi L, Yang J, Zhang R, Xie Z, Wang H. Temporal landscape and translational regulation of A-to-I RNA editing in mouse retina development. BMC Biol. 2024;22:106.","journal-title":"BMC Biol"},{"key":"9602_CR24","doi-asserted-by":"publisher","first-page":"112340","DOI":"10.1016\/j.intimp.2024.112340","volume":"136","author":"J Mao","year":"2024","unstructured":"Mao J, Li J, Lu X, Zhong H, Zhao Y, Zhu L, Fu H, Ding G, Teng F, Chen M, Guo W. Dichotomous roles of ADAR1 in liver hepatocellular carcinoma and kidney renal cell carcinoma: Unraveling the complex tumor microenvironment and prognostic significance. Int Immunopharmacol. 2024;136:112340.","journal-title":"Int Immunopharmacol"},{"key":"9602_CR25","doi-asserted-by":"crossref","unstructured":"C X C, D S C, Q W FL, K C C, K NJR. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. RNA. 2000;6:755\u201367.","DOI":"10.1017\/S1355838200000170"},{"key":"9602_CR26","doi-asserted-by":"crossref","unstructured":"Meng How T, Qin L, Raghuvaran S, Robert P, Jennefer K, Amy NY, Kaiwen Ivy L, Rui Z, Gokul R, Kentaro A, Ankita G, Liam PK, Cyril XG, Avinash R, Ni H, Elizabeth AP, Dena SL, Alessandra R, Sharon YP, Ajay G, Giannino C, Gary DS, Anne P, Donald B, Charles FC, Mary ES, Carl AOC, Kazuko RW, Jin N, Billy LJN. Dynamic landscape and regulation of RNA editing in mammals. Nature. 2017;550:249\u201354.","DOI":"10.1038\/nature24041"},{"key":"9602_CR27","doi-asserted-by":"publisher","first-page":"113704","DOI":"10.1016\/j.celrep.2024.113704","volume":"43","author":"M Rivera","year":"2024","unstructured":"Rivera M, Zhang H, Pham J, Isquith J, Zhou Q, Balaian L, Sasik R, Enlund S, Mark A, Ma W, Holm F, Fisch K, Kuo D, Jamieson C, Jiang Q. Malignant A-to-I RNA editing by ADAR1 drives T cell acute lymphoblastic leukemia relapse via attenuating dsRNA sensing. Cell Rep. 2024;43:113704.","journal-title":"Cell Rep"},{"key":"9602_CR28","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1038\/s41467-023-38581-8","volume":"14","author":"T Wong","year":"2023","unstructured":"Wong T, Loh J, Lu S, Yan H, Siu H, Xi R, Chan D, Kam M, Zhou L, Tong M, Copland J, Chen L, Yun J, Leung S, Ma S. ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer. Nat Commun. 2023;14:2861.","journal-title":"Nat Commun"},{"key":"9602_CR29","first-page":"845","volume":"54","author":"Y Jiao","year":"2019","unstructured":"Jiao Y, Yang H, Qian J, Gong Y, Liu H, Wu S, Cao L, Tang L. miR\u20133664\u20135P suppresses the proliferation and metastasis of gastric cancer by attenuating the NF\u2013\u03baB signaling pathway through targeting MTDH. Int J Oncol. 2019;54:845\u201358.","journal-title":"Int J Oncol"},{"key":"9602_CR30","doi-asserted-by":"crossref","unstructured":"Ghanbarian M, Afgar A, Yadegarazari R, Najafi R, Teimoori-Toolabi L. Through oxaliplatin resistance induction in colorectal cancer cells, increasing ABCB1 level accompanies decreasing level of miR-302c-5p, miR-3664-5p and miR-129-5p. Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie. 2018;108:1070\u201380.","DOI":"10.1016\/j.biopha.2018.09.112"},{"key":"9602_CR31","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s12672-024-01462-7","volume":"15","author":"S Xu","year":"2024","unstructured":"Xu S, Zhou G, He Q, Ding J, Liu X, Cheng Y, Shen Y. A-to-I-edited miR-1251-5p restrains tumor growth and metastasis in lung adenocarcinoma through regulating TCF7-mediated Wnt signaling pathway. Discover Oncol. 2024;15:587.","journal-title":"Discover Oncol"},{"key":"9602_CR32","doi-asserted-by":"publisher","first-page":"16602","DOI":"10.1038\/s41598-023-43775-7","volume":"13","author":"G Voss","year":"2023","unstructured":"Voss G, Cassidy J, Ceder Y. Functional consequences of A-to-I editing of miR-379 in prostate cancer cells. Sci Rep. 2023;13:16602.","journal-title":"Sci Rep"},{"key":"9602_CR33","doi-asserted-by":"crossref","unstructured":"Thorsten N, Min-Chun C, Nils W, Sinem U, Rupert O, Svenja L, Michael D, Tobias M, Martin J, Katja S, Werner S, Henrik E, Roland MS. Metabolic Reprogramming Is an Initial Step in Pancreatic Carcinogenesis That Can Be Targeted to Inhibit Acinar-to-Ductal Metaplasia. Cancer Res. 2024;84:2297\u2013312.","DOI":"10.1158\/0008-5472.CAN-23-2213"}],"container-title":["Journal of Mammary Gland Biology and Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10911-026-09602-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10911-026-09602-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10911-026-09602-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T22:51:20Z","timestamp":1785711080000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10911-026-09602-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["9602"],"URL":"https:\/\/doi.org\/10.1007\/s10911-026-09602-1","relation":{},"ISSN":["1083-3021","1573-7039"],"issn-type":[{"value":"1083-3021","type":"print"},{"value":"1573-7039","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Samples were collected with ethical approval from the Ethics Committee of the Fifth People\u2019s Hospital of Datong, following the Helsinki principles, and patients did not receive chemotherapy or radiotherapy. Prior to enrollment, all patients gave written consent after being informed. The study was approved by the Animal Ethics Committee of the Fifth People\u2019s Hospital of Datong.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors agree that the work will be published in a journal and understand and agree to the full terms and conditions of its publication.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"19"}}